Hamzah Syed
Overview
Explore the profile of Hamzah Syed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erdogan Kablan S, Yilmaz A, Syed H, Kocabeyoglu S, Kervan U, Ozaltin N, et al.
Rapid Commun Mass Spectrom
. 2024 Mar;
38(9):e9728.
PMID: 38482917
Rationale: Acute renal failure (ARF) is one of the most serious complications of cardiopulmonary bypass (CPB) surgery. Serum creatinine level is a key compound examined to understand whether renal function...
2.
Cevatemre B, Bulut I, Dedeoglu B, Isiklar A, Syed H, Bayram O, et al.
Cell Death Dis
. 2024 Feb;
15(2):132.
PMID: 38346967
The development of taxane resistance remains a major challenge for castration resistant prostate cancer (CR-PCa), despite the effectiveness of taxanes in prolonging patient survival. To uncover novel targets, we performed...
3.
Ozyerli-Goknar E, Kala E, Aksu A, Bulut I, Cingoz A, Nizamuddin S, et al.
Cell Commun Signal
. 2023 Nov;
21(1):328.
PMID: 37974198
Background: Glioblastoma is the most common and aggressive primary brain tumor with extremely poor prognosis, highlighting an urgent need for developing novel treatment options. Identifying epigenetic vulnerabilities of cancer cells...
4.
Yedier-Bayram O, Gokbayrak B, Kayabolen A, Aksu A, Cavga A, Cingoz A, et al.
Cell Death Dis
. 2022 Aug;
13(8):710.
PMID: 35973998
Dysregulation of the epigenome due to alterations in chromatin modifier proteins commonly contribute to malignant transformation. To interrogate the roles of epigenetic modifiers in cancer cells, we generated an epigenome-wide...
5.
Alseed M, Syed H, Onbasli M, Yetisen A, Tasoglu S
Micromachines (Basel)
. 2021 Aug;
12(8).
PMID: 34442504
Civil wars produce immense humanitarian crises, causing millions of individuals to seek refuge in other countries. The rate of disease prevalence has inclined among the refugees, increasing the cost of...
6.
Syed H, Jorgensen A, Morris A
BMC Bioinformatics
. 2017 May;
18(1):265.
PMID: 28525968
Background: Analysis of genome-wide association studies (GWAS) with "time to event" outcomes have become increasingly popular, predominantly in the context of pharmacogenetics, where the survival endpoint could be death, disease...
7.
Syed H, Jorgensen A, Morris A
BMC Bioinformatics
. 2016 Dec;
17(1):523.
PMID: 27931206
Background: Power calculators are currently available for the design of genetic association studies of binary phenotypes and quantitative traits, but not for "time to event" outcomes, which are of particular...
8.
Syed H, Jorgensen A, Morris A
Pharmacogenomics
. 2016 Jun;
17(8):907-15.
PMID: 27248145
Aim: To evaluate the power to detect associations between SNPs and time-to-event outcomes across a range of pharmacogenomic study designs while comparing alternative regression approaches. Materials & Methods: Simulations were...